Explore more publications!
Tajikistan Tech Daily
Got News to Share?

Tajikistan Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Tech Daily.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 24, 2025

Imviva Biotech Announces Seven Presentations Highlighting its ANSWER™ Allogeneic CAR-T Platform at the 67th American Society of Hematology Annual Meeting
November 24, 2025

Imviva Biotech Announces Seven Presentations Highlighting its ANSWER™ Allogeneic CAR-T Platform at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
NordVPN call protection now available for Android users in the UK and Canada
November 24, 2025

NordVPN call protection now available for Android users in the UK and Canada

Indeterminate GlobeNewswire
Ramsey Theory Group CEO Dan Herbatschek Identifies the Three Most Significant Cybersecurity Threats for Businesses Coming in December 2025
November 24, 2025

Ramsey Theory Group CEO Dan Herbatschek Identifies the Three Most Significant Cybersecurity Threats for Businesses Coming in December 2025

Indeterminate GlobeNewswire
Texas Border Agency Selects New Non-Lethal Response Subscription to Strengthen Officer and Community Safety
November 24, 2025

Texas Border Agency Selects New Non-Lethal Response Subscription to Strengthen Officer and Community Safety

Indeterminate GlobeNewswire
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
November 24, 2025

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Indeterminate GlobeNewswire
BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality
November 24, 2025

BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality

Indeterminate GlobeNewswire
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
November 24, 2025

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Indeterminate GlobeNewswire
Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting
November 24, 2025

Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting

Indeterminate GlobeNewswire
Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations
November 24, 2025

Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations

Indeterminate GlobeNewswire
IP Strategy Announces Availability of Investor Day 2025 Materials
November 24, 2025

IP Strategy Announces Availability of Investor Day 2025 Materials

Indeterminate GlobeNewswire
Annovis Announces Two Presentations at the CTAD 2025 Conference
November 24, 2025

Annovis Announces Two Presentations at the CTAD 2025 Conference

Indeterminate GlobeNewswire
ProMIS Neurosciences Announces Reverse Stock Split
November 24, 2025

ProMIS Neurosciences Announces Reverse Stock Split

Indeterminate GlobeNewswire
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
November 24, 2025

Neuphoria Therapeutics Inc. Sends Letter to Stockholders

Indeterminate GlobeNewswire
Applied Digital Completes Phase II Ready for Service at Polaris Forge 1, Fully Energizing First 100 MW Building
November 24, 2025

Applied Digital Completes Phase II Ready for Service at Polaris Forge 1, Fully Energizing First 100 MW Building

Indeterminate GlobeNewswire
Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
November 24, 2025

Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

Indeterminate GlobeNewswire
LINK FOREX presents an innovative “investment as a side hustle” model to redefine global financial equity
November 24, 2025

LINK FOREX presents an innovative “investment as a side hustle” model to redefine global financial equity

Indeterminate GlobeNewswire
LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025

LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
GigaCloud Technology Inc to Participate in UBS Global Technology and AI Conference
November 24, 2025

GigaCloud Technology Inc to Participate in UBS Global Technology and AI Conference

Indeterminate GlobeNewswire
Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025

Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers
November 24, 2025

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions